Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis (Q73292505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

pancreatic adenocarcinoma

2 November 2019

main subject

1 reference

1 reference

Hinz S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Trauzold A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Boenicke L

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sandberg C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Beckmann S

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Bayer E

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Walczak H

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Kalthoff H

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ungefroren H

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

5477-5486

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114725%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203936

2 November 2019

exact match

0 references

cites work

The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Ectopic expression of Bcl-2, but not Bcl-xL rescues Ramos B cells from Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Inhibition of Fas-induced apoptosis by Bcl-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Over-expression of bcl-xL gene in human gastric adenomas and carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Different mechanisms of bone metabolism between patients with stroke and with spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

The proto-oncogene Bcl-2 and its role in regulating apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Overexpression of Bcl-x(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Bcl-2 family proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

FAP-1: a protein tyrosine phosphatase that associates with Fas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Two CD95 (APO-1/Fas) signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Mitochondrial release of caspase-2 and -9 during the apoptotic process

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Transcriptional regulation of the human biglycan gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021

TRAIL causes cleavage of bid by caspase-8 and loss of mitochondrial membrane potential resulting in apoptosis in BJAB cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203936

7 January 2021